BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:27th Pharmacovigilance 2022\n\n“Latest developments in pharmac ovigilance\, drug safety and risk management”\n\n23rd &\; 24th Februar y 2022\, Pestana Chelsea Bridge Hotel London\, UK\n\nAfter the successful journey of a series of 26 Pharmacovigilance conferences\, Virtue Insight is proud to announce its \;27th Pharmacovigilance 2022. We have been delivering the conference through close collaboration with the industry leaders for \;more than a decade. For the 2022 edition\, the agenda i ncludes a host of new and exciting features focusing on how the industry should evolve especially after the pandemic. Take a chance and make it co unt by attending our event to network with your peers\, exchange expertis e and experiences\, and arm yourself with the latest information to take your department to the next level.\n\nSPONSORS:\n\nBRONZE SPONSOR - ProPh arma Group\n\nASSOCIATE SPONSOR - Brookwood\n\nDELEGATE REGISTRATION:\n\n Email - kavitha@virtueinsight.co.in or TEL: +44-20 3509 3779 \n\nPlease n ote that this is a PAID event and NOT A FREE event (no complimentary pass es available). Any invite\, email or tickets issued mentioning it as a fr ee pass or free ticket to this event through any third party site will st rictly not be accepted by the organizer.\n\nSuper Early Discount - Valid till 06th December 2021\n\n1 Delegate @ £699+20% VAT \;\n\n3 Delegate s @ £1\,398+20% VAT\n\nEarly Discount - Valid till 20th January 2022\n\n1 Delegate @ £999+20% VAT \;\n\n3 Delegates @ £1\,998+20% VAT \;\n \nStandard Pricing - From 21st January 2022\n\n1 Delegate @ £1\,299+20% V AT \;\n\n3 Delegates @ £2\,598+20% VAT \;\n\nConference Sponsor\, Exhibition Stall &\; Paid Speaker Slot - Please email your interest a nd queries to kavitha@virtueinsight.co.in \;\n\nKEY SPEAKERS:\n\n\nKH AUDEJA BANO\, Executive Medical Director\, Combination Product Safety Hea d\, Amgen (USA)\nSUMIT MUNJAL\, Vice President\, Global Patient Safety Ev aluation\, Takeda Pharmaceuticals\nFABIO DE GREGORIO\, Vice President\, H ead of Drug Safety Europe\, EU QPPV\, Shionogi Europe\nMOHAMED ABDILLAHI\ , Director\, Risk management Product Lead\, Pfizer\nWIVINA DE WAELE\, Dir ector EMEA\, Global Drug Safety\, Alexion Pharmaceuticals\nRISHI CHOPRA\, Senior Director\, Head of International PV | Deputy EU UK QPPV\, Biogen\ nJOHN SOLOMON\, Head of Pharmacovigilance - UK &\; Ireland\, Sanofi\nJ AMES WHITEHEAD\, Director and Team Lead - Patient Safety Medical Devices &\; Digital Health\, AstraZeneca\nKLAUDIJA MARIJANOVIC BARAC\, Direct or\, Global Patient Safety &\; PV - TPC\, Teva\nMARIA MADDALENA LINO\, Safety Risk Lead Director\, Pfizer\nPAV RISHIRAJ\, Director (UK QPPV)\, Head of Patient Safety – UK and Ireland &\; ABPI PV Expert Chair\, Mer ck\nMIRCEA CIUCA\, Global Therapeutic Area Head - Global Clinical Safety &\; PV\, CSL Behring\nRAJ BHOGAL\, Senior Director\, R&\;D Audits & amp\; Inspections\, Jazz Pharmaceuticals\nVALENTINA MANCINI\, Director PV \, EU QPPV\, Shionogi\nTEA BABIC\, Dir – Audits and Inspections\, Teva\n SHAANTANU DONDE\, Head of Portfolio Management Team - Medical Affairs\, V iatris\nUWE GUDAT\, Head of Medical Affairs &\; CSPV\, Fresenius Kabi\ nRICARDA TIEMEYER\, Associate Director Head of Pharmacovigilance\, Biogen \nHOWARD SNOW\, VP\, Head of Pharmacovigilance\, Hengrui Therapeutics\nWA LLY LANDSBERG\, Vice President\, Global Head of Medical Safety\, Kyowa Ki rin\nRANJANA KHANNA\, Director &\; Head Pharmacovigilance Quality Assu rance\, Vifor Pharma\nYVONNE NANCIU\, Country Head Pharmacovigilance\, Ba yer\nALESSANDRO VAGHEGGINI\, Associate Principal Biostatistician\, Clinic al Safety Statistics\, MSD (CH)\nAMGAD SHEBL\, Director\, Global Clinical Safety &\; PV / Clinical R&\;D\, CSL Behring\nRUDI SCHEERLINCK\, E xecutive Director Safety Evaluation &\; Risk Management\, Galderma\nAL INA TU DOR\, Senior Director\, Pharmacovigilance\, Kyowa Kirin Internatio nal\nPHILIP OLUWOLE\, PFO PV Consulting\nFRANCK SCHWARTZ\, QA Global Insp ection\, Intelligence Lead - Compliance &\; Regulatory Affairs\, Novar tis\nDIMITRIS ZAMPATIS\, Head of Pharmacovigilance EMEA-EEA QPPV\, Lupin\ nMINHAJ OBEIDULLAH\, Head Compliance &\; Risk Management\, Novartis\nC HETAN SHATAPATHY\, Consultant Medical Advisor\, Office of the (QPPV) (Int erim)\, Janssen Pharmaceutical\nJEAN-KILGOUR CHRISTIE\, Deputy EU QPPV\, Novartis\nDANIELA DI COSMO\, Senior PV Manager\, Global PV\, Ferring Phar maceuticals\nNICOLE BAKER\, Co-Founder\, BioLogit\nMICHAEL RAMCHARAN\, Ma naging Director\, Reumat Consulting\nMARINA SUVAKOV\, Global Head Safety Surveillance\, Philip Morris International\nSANDY EISEN\, Chief Medical O fficer\, Frontline Pharma Consulting\nALEXANDER ROUSSANOV\, International Partner\, Life Sciences and Privacy\, Arnold &\; Porter\n\nPlus more joining soon\n\nKEY THEMES DISCUSSED:\n\n\nRising back and getting back o n track from the pandemic - Lessons learnt from the pandemic\nMarket anal ysis – Pharmacovigilance in 2022 - future horizons and efficiencies\nImpr oving the PV ecosystem for advancement – Rising back from the pandemic\nI mplementation of the new EU Clinical Trial rules - and the impacts on saf ety departments\nOutsourcing in Pharmacovigilance- Best Practices\, Chall enges and key consideration\nDocumentation (RMPs\, PSURs\, PADERs\, PBRER s)\nQuality\, Safety &\; Signal Detection – Peep into the future\nRisk Management Plan and Pharmacovigilance System - New Paradigm\nPharmacovig ilance Audits: Keeping on the right side of inspectors\nMedical devices – Increasing safety perspective\nCase studies from various countries on th e PV frameworks around the world\nPrioritising Patients - Reshaping patie nt safety\nBrexit Implications for the Pharmaceutical (pharmacovigilance) Industry\nNew Technologies in Pharmacovigilance (AI/ Machine Learning\, IoT)\nThe developing regulatory framework in advanced and developing mark ets – EU\, USA &\; ROW\nBe part of a major networking opportunity\n\nW HO SHOULD ATTEND:\n\nCEO’s\, CTO’s\, CIO’s\, Presidents\, VPs\, Directors \, Heads\, Managers\, Scientific Advisors\, Consultants of:\n\nPharmacovi gilance\, Pharmacoepidemiology\, Pharmacogenomics\, Drug/Product Safety\, Drug Development\, Information and Clinical Data Management\, Clinical P harmacology\, Clinical Safety\, Periodical safety update Reports\, Risk M anagement\, Research &\; Development\, Quality Assurance\, Patient Saf ety\, Signal Detection\, Safety Surveillance\, Outcomes Research\, Data A nalysis\, Epidemiology\, Medical Affairs\, Regulatory Affairs and Complia nce\, Information technology\, Sales and Marketing\n\nGet more from the e vent\, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time\, meet the leading international vendors showcasing the products of tomorr ow in the co-located exhibition. Expand your knowledge of the latest busi ness models and strategies in the high-level conference.\n DTEND:20220224T170000 DTSTAMP:20260512T214302Z DTSTART:20220223T093000 LOCATION:Pestana Chelsea Bridge Hotel\, 354\, Queenstown Road\, London\, G reater London\, SW11 8AE\, SEQUENCE:0 SUMMARY:27th Pharmacovigilance 2022\n“Latest developments in pharmacovigil ance\, drug safety and risk management”\n23rd &\; 24th February 2022\, Pestana Ch... UID:d0d46bd5-63d2-42ee-8c26-a26de66ec52a END:VEVENT END:VCALENDAR